Melissa A. Yeager, J.D.
SVP Regulatory Affairs and Quality
Jaguar Health
Melissa A. Yeager, J.D.
Melissa joins Jaguar Health with 20 years of experience developing biopharmaceuticals. Companies she has lead regulatory affairs are: Alder Pharmaceuticals, Breath Therapeutics, Gilead, and Corus.
Melissa brings strategic thinking, team building and a track record of product approvals to the Jaguar Health portfolio.
Welcome to The Jaguar Health team, Melissa!
Jaguar Health, Inc. (NASDAQ: JAGX) is a commercial stage pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products on a global basis. Their wholly-owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Their Mytesi® (crofelemer) product is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.  
Learn more at